agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 5.24% | -9.47% | |||
| Total Other Revenue | -4.66% | -23.71% | |||
| Total Revenue | 5.23% | -9.50% | |||
| Cost of Revenue | 2.37% | -18.35% | |||
| Gross Profit | 64.79% | 171.71% | |||
| SG&A Expenses | 68.07% | -18.12% | |||
| Depreciation & Amortization | 1.13% | -2.61% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.61% | -18.28% | |||
| Operating Income | 91.94% | 106.46% | |||
| Income Before Tax | -41.29% | 115.97% | |||
| Income Tax Expenses | -1,439.29% | -97.89% | |||
| Earnings from Continuing Operations | -39.98% | 115.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -63.29% | 125.90% | |||
| EBIT | 91.94% | 106.46% | |||
| EBITDA | 55.47% | 111.07% | |||
| EPS Basic | -63.52% | 125.88% | |||
| Normalized Basic EPS | -30.51% | 124.00% | |||
| EPS Diluted | -64.63% | 125.82% | |||
| Normalized Diluted EPS | -32.30% | 123.91% | |||
| Average Basic Shares Outstanding | 0.64% | 0.09% | |||
| Average Diluted Shares Outstanding | 3.31% | 0.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||